Insider: Meyer Andrew Hollman Chief Business Officer - Janux Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 83,095 | 0 | 83,095 |
| Value | $1,221,081.03 | $0.00 | $1,221,081.03 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/02/2026 | DDS | 1,879 | Direct | COM | $13.73 | $25,798.67 | 83,095 |
| 12/01/2025 | DDS | 2,700 | Direct | COM | $32.85 | $88,707.96 | 85,607 |
| 12/01/2025 | DDS | 633 | Direct | COM | $33.52 | $21,221.14 | 84,974 |
| 11/14/2025 | DDS | 3,333 | Direct | COM | $30.00 | $99,990.00 | 84,974 |
| 10/28/2025 | DDS | 16,665 | Direct | COM | $30.06 | $500,986.56 | 82,139 |
| 05/01/2025 | DDS | 2,933 | Direct | COM | $31.95 | $93,703.19 | 82,539 |
| 05/01/2025 | DDS | 400 | Direct | COM | $32.60 | $13,041.36 | 82,139 |
| 04/21/2025 | DDS | 3,334 | Direct | COM | $30.00 | $100,020.00 | 82,139 |
| 03/03/2025 | DDS | 2,433 | Direct | COM | $31.88 | $77,575.72 | 83,040 |
| 03/03/2025 | DDS | 901 | Direct | COM | $32.85 | $29,598.66 | 82,139 |
| 02/03/2025 | DDS | 2,418 | Direct | COM | $42.08 | $101,738.80 | 83,055 |
| 02/03/2025 | DDS | 816 | Direct | COM | $42.77 | $34,900.56 | 82,239 |
| 02/03/2025 | DDS | 100 | Direct | COM | $43.60 | $4,360.00 | 82,139 |
| 01/02/2025 | DDS | 2,922 | Direct | COM | $53.76 | $157,081.46 | 92,551 |
| 01/02/2025 | DDS | 5,768 | Direct | COM | $54.51 | $314,420.02 | 86,783 |
| 01/02/2025 | DDS | 200 | Direct | COM | $57.37 | $11,473.00 | 82,139 |
| 01/02/2025 | DDS | 3,444 | Direct | COM | $55.76 | $192,032.96 | 83,339 |
| 01/02/2025 | DDS | 1,000 | Direct | COM | $56.78 | $56,777.80 | 82,339 |
| 09/27/2024 | DDS | 50,000 | Direct | COM | $45.96 | $2,297,755.00 | 67,592 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research